A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing.Swiss drugmaker ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

In a breakthrough study, microbiologists at Brunel University London discovered that Pseudomonas aeruginosa, a common and ...

The first new antibiotic in 50 years to tackle a common superbug will be tested on patients. The drug, which targets one of ...

Pseudomonas aeruginosa is associated with 559,000 yearly deaths worldwide, and many of them come from hospital-acquired ...

A nasty bacterial superbug that kills hundreds of thousands of people per year is spreading through hospitals — and ...

A new antibiotic that could treat a common ‘superbug’ is to be tested on patients. The drug Zosurabalpin, is being developed ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

If successful, it would be the first new class of drug against certain bacteria strains for more than 50 years ...

A study reveals that the superbug Pseudomonas aeruginosa can digest medical plastics, posing a threat to patient safety globally. The bacterium uses the plastic as a carbon source, potentially leading ...

Hundreds of patients will be recruited for a major trial of what could be the first new antibiotic of its kind for 50 years.

The bacterium, Pseudomonas aeruginosa, is responsible for up to 30 per cent of hospital-acquired infections, a new study has ...